Effects of immobilization on a FRET immunosensor for the detection of myocardial infarction

A novel optical biosensor technique is being developed for the early detection of myocardial infarction by utilizing the distance-dependent chemical transduction method of fluorescence resonance energy transfer (FRET). The FRET process requires two fluorophores termed the donor and the acceptor. When in close proximity, the donor absorbs energy from the excitation source and non-radiatively transfers the energy to the acceptor, which in turn emits fluorescent energy. This distance-dependent property was utilized to detect conformational changes when antibodies combine with their respective antigens. The fluorophores were conjugated to an antibody–Protein A complex and then immobilized via silanization to the distal ends of optical fibers. Three different antibody–Protein A complexes were immobilized: generic IgG, cardiac Troponin T (cTnT), and cardiac Troponin I (cTnI). Results showed that upon the addition of the specific antigens, the antibodies underwent a conformational change, reducing the distance between the FRET fluorophores. The generic IgG responded to 233 nM antigens, whereas the cTnT biosensor had a limit of detection of 75 nM, and the cTnI biosensors had a limit of detection of 94 nM.

[1]  A. Jaffe,et al.  It's time for a change to a troponin standard. , 2000, Circulation.

[2]  Oliver Mf,et al.  The atheromatous lipid core. , 1998 .

[3]  F. Dati,et al.  Use of Biochemical Markers in Acute Coronary Syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage , 1999, Clinical chemistry and laboratory medicine.

[4]  A. Remppis,et al.  Development and characterization of a rapid assay for bedside determinations of cardiac troponin T. , 1995, Circulation.

[5]  M. Panteghini,et al.  The Sensitivity of Cardiac Markers: an Evidence-based Approach , 1999, Clinical chemistry and laboratory medicine.

[6]  Gaudenz Danuser,et al.  FRET or no FRET: a quantitative comparison. , 2003, Biophysical journal.

[7]  D. S. Luciano,et al.  Human Physiology: The Mechanism of Body Function , 1975 .

[8]  S. Grant,et al.  A Novel Sensing Technique to Detect Thrombin , 2004 .

[9]  P O Collinson,et al.  Troponin T or troponin I or CK-MB (or none?). , 1998, European heart journal.

[10]  S. Grant,et al.  Development of a novel FRET immunosensor technique. , 2003, Biosensors & bioelectronics.

[11]  J M Calvert,et al.  Use of thiol-terminal silanes and heterobifunctional crosslinkers for immobilization of antibodies on silica surfaces. , 1989, Analytical biochemistry.

[12]  J. Lakowicz Principles of fluorescence spectroscopy , 1983 .

[13]  W. Gibler,et al.  National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. , 1999, Clinical chemistry.

[14]  H. Katus,et al.  Biochemical markers in the diagnosis of coronary artery disease. , 1998, European heart journal.

[15]  J. Mair Tissue Release of Cardiac Markers: from Physiology to Clinical Applications , 1999, Clinical chemistry and laboratory medicine.